Dr. Bogoch mentioned it, and he stole the words right out of my mouth.
Pharmacies and pharmacists are not only in every community, but we're also supplied by a very robust supply chain that allows us to have timely access to these therapies in every single community. At the moment, depending on the province.... Obviously, the jurisdictions and the provinces vary in the scope of practice and ability of pharmacists to prescribe certain products. Dr. Bogoch mentioned that these products should be available without prescription, and pharmacists can still counsel, supply, educate and ensure that these products are made available to the right patients in an equitable, accessible and safe way.
In terms of regulatory barriers, if it is not a prescribed product, it's a question of supply, of access and of its being available through the pharmacy sector, which, in many provinces right now, it is not. It is restricted to primary [Technical difficulty—Editor] testing or public health centres.
I think it's more of a planning question and making it accessible to the pharmacy sector to make it accessible to Canadians.